Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report)’s share price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.01 and traded as high as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 234,744 shares changing hands.
Evofem Biosciences Stock Performance
The company has a market capitalization of $1.13 million, a price-to-earnings ratio of -0.02 and a beta of -0.90. The business’s 50 day moving average is $0.01 and its 200 day moving average is $0.01.
About Evofem Biosciences
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Featured Articles
- Five stocks we like better than Evofem Biosciences
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- Stock Sentiment Analysis: How it Works
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- Election Stocks: How Elections Affect the Stock Market
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
